Adrenergic, alpha-2C-, Receptor (ADRA2C) (Extracellular Domain), (N-Term) antibody

Details for Product No. ABIN1731581
Antigen
Epitope
N-Term, Extracellular Domain
46
37
19
9
7
4
3
3
2
2
2
2
1
1
1
1
1
Reactivity
Human
134
88
44
6
4
3
1
1
Host
Rabbit
86
54
Clonality
Polyclonal
Conjugate
Un-conjugated
6
5
5
4
4
4
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
Application
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
109
43
35
29
28
25
19
13
4
4
3
1
Options
Immunogen Synthetic 18 amino acid peptide from N-terminal extracellular domain of human ADRA2C. Percent identity with other species by BLAST analysis: Human (100%), Gorilla (100%), Gibbon (100%), Monkey (100%), Dog (89%), Rat (83%), Guinea pig (83%).
Isotype IgG
Specificity Reacts with human ADRA2C
Cross-Reactivity (Details) BLAST analysis of the peptide immunogen showed no homology with other human proteins.
Purification Antigen affinity purified
Antigen
Alternative Name ADRA2C (ADRA2C Antibody Abstract)
Background Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins.
UniProt P18825
Pathways EGFR Signaling Pathway, cAMP Metabolic Process
Application Notes

Working dilution: IHC - P (26 μg/mL

Restrictions For Research Use only
Format Liquid
Concentration 1 mg/mL
Buffer PBS, Sodium azide 0.1 %
Preservative Sodium azide
Precaution of Use This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C/-80 °C
Storage Comment Long term: -70°C, Short term: +4°C
Supplier Images
Image no. 1 for anti-Adrenergic, alpha-2C-, Receptor (ADRA2C) (Extracellular Domain), (N-Term) antibody (ABIN1731581) anti-Adrenergic, alpha-2C-, Receptor (ADRA2C) (Extracellular Domain), (N-Term) antibody